Skip to main content
Erschienen in: Heart and Vessels 8/2023

28.03.2023 | Original Article

Acute coronary syndrome in very elderly patients—a real-world experience

verfasst von: Matteo Bianco, Filiberto Fausto Mottola, Enrico Cerrato, Francesca Giordana, Sebastian Cinconze, Giorgio Baralis, Alison Verra, Giuseppe Musumeci, Roberta Rossini

Erschienen in: Heart and Vessels | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Very elderly population constitutes an increasingly larger proportion of patients admitted for acute coronary syndromes (ACS). Notably, age represents both a proxy of frailty and an exclusion criterion in clinical randomized trials, which probably contributes to lack of data and undertreatment of real-world elderly patients. The aim of the study is to describe patterns of treatment and outcome of very elderly patients with ACS. All consecutive patients aged ≥ 80 years old (yo) admitted between January 2017 and December 2019 with ACS were included. The primary endpoint was in-hospital occurrence of major adverse cardiovascular events (MACE), defined as the composite of cardiovascular death, new onset cardiogenic shock, definite/probable stent thrombosis, and ischemic stroke. The secondary endpoints were in-hospital incidence of Thrombolysis in Myocardial Infarction (TIMI) major/minor bleedings, contrast-induced nephropathy (CIN), six-month all-cause mortality, and unplanned readmission. One hundred ninety-three patients (mean age 84.1 ± 3.5 yo, 46% females) were included, of whom 86 (44.6%), 79 (40.9%), and 28 (14.5%) presented with ST elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina (UA), respectively. The vast majority of patients received an invasive strategy, with 92.7% undergoing coronary angiography and 84.4% to percutaneous coronary intervention (PCI). Aspirin was administered to 180 (93.3%) patients, clopidogrel to 89 (46.1%) patients, and ticagrelor to 85 (44%) patients. In-hospital MACE occurred in 29 patients (15.0%), whereas 3 (1.6%) and 12 patients (7.2%) experienced in-hospital TIMI major and TIMI minor bleeding, respectively. Of the overall population, 177 (91.7%) were discharged alive. After discharge, 11 patients (6.2%) died of all-cause death, whereas 42 patients (23.7%) required a new hospitalization within six months. Invasive strategy of ACS in elderly patients seems safe and effective. Six-month new hospitalization appears inevitably related to age.
Literatur
1.
Zurück zum Zitat Rich MW, Chyun DA, Skolnick AH, Alexander KP, Forman DE, Kitzman DW, Maurer MS, McClurken JB, Resnick BM, Shen WK, Tirschwell DL; American Heart Association Older Populations Committee of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council; American College of Cardiology; and American Geriatrics Society (2016) Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the American heart association, American college of cardiology, and American geriatrics society. J Am Coll Cardiol 67(20):2419–2440CrossRef Rich MW, Chyun DA, Skolnick AH, Alexander KP, Forman DE, Kitzman DW, Maurer MS, McClurken JB, Resnick BM, Shen WK, Tirschwell DL; American Heart Association Older Populations Committee of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council; American College of Cardiology; and American Geriatrics Society (2016) Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the American heart association, American college of cardiology, and American geriatrics society. J Am Coll Cardiol 67(20):2419–2440CrossRef
2.
Zurück zum Zitat Leonardi S, Bueno H, Ahrens I, Hassager C, Bonnefoy E, Lettino M (2018) Optimised care of elderly patients with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 7(3):287–295CrossRefPubMed Leonardi S, Bueno H, Ahrens I, Hassager C, Bonnefoy E, Lettino M (2018) Optimised care of elderly patients with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 7(3):287–295CrossRefPubMed
3.
Zurück zum Zitat Li L, Geraghty OC, Mehta Z, Rothwell PM; Oxford Vascular Study (2017) Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet 390(10093):490–499CrossRef Li L, Geraghty OC, Mehta Z, Rothwell PM; Oxford Vascular Study (2017) Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet 390(10093):490–499CrossRef
4.
Zurück zum Zitat Savonitto S, Cavallini C, Petronio AS, Murena E, Antonicelli R, Sacco A, Steffenino G, Bonechi F, Mossuti E, Manari A, Tolaro S, Toso A, Daniotti A, Piscione F, Morici N, Cesana BM, Jori MC, De Servi S, Italian Elderly ACS, Investigators T (2012) Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial. JACC Cardiovasc Interv 5(9):906–916CrossRefPubMed Savonitto S, Cavallini C, Petronio AS, Murena E, Antonicelli R, Sacco A, Steffenino G, Bonechi F, Mossuti E, Manari A, Tolaro S, Toso A, Daniotti A, Piscione F, Morici N, Cesana BM, Jori MC, De Servi S, Italian Elderly ACS, Investigators T (2012) Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial. JACC Cardiovasc Interv 5(9):906–916CrossRefPubMed
5.
Zurück zum Zitat Capranzano P, Angiolillo DJ (2020) Ticagrelor or Clopidogrel in elderly patients with myocardial infarction: when the choice makes the difference. Circulation 142(18):1709–1712CrossRefPubMed Capranzano P, Angiolillo DJ (2020) Ticagrelor or Clopidogrel in elderly patients with myocardial infarction: when the choice makes the difference. Circulation 142(18):1709–1712CrossRefPubMed
6.
Zurück zum Zitat Capranzano P, Angiolillo DJ (2021) Antithrombotic management of elderly patients with coronary artery disease. JACC Cardiovasc Interv 14(7):723–738CrossRefPubMed Capranzano P, Angiolillo DJ (2021) Antithrombotic management of elderly patients with coronary artery disease. JACC Cardiovasc Interv 14(7):723–738CrossRefPubMed
7.
Zurück zum Zitat Holzmann MJ, Siddiqui AJ (2020) Outcome of percutaneous coronary intervention during non-st-segment-elevation myocardial infarction in elderly patients with chronic kidney disease. J Am Heart Assoc 9(12):e015084CrossRefPubMedPubMedCentral Holzmann MJ, Siddiqui AJ (2020) Outcome of percutaneous coronary intervention during non-st-segment-elevation myocardial infarction in elderly patients with chronic kidney disease. J Am Heart Assoc 9(12):e015084CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators (2017) Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 389(10073):1025–1034CrossRef Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators (2017) Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet 389(10073):1025–1034CrossRef
9.
Zurück zum Zitat Fox KA, Eagle KA, Gore JM, Steg PG, Anderson FA, GRACE and GRACE2 Investigators (2010) The global registry of acute coronary events, 1999 to 2009–GRACE. Heart 96(14):1095–1101CrossRefPubMed Fox KA, Eagle KA, Gore JM, Steg PG, Anderson FA, GRACE and GRACE2 Investigators (2010) The global registry of acute coronary events, 1999 to 2009–GRACE. Heart 96(14):1095–1101CrossRefPubMed
10.
Zurück zum Zitat Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; ESC Scientific Document Group (2019) Fourth universal definition of myocardial infarction (2018). Eur Heart J 40(3):237–269CrossRef Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; ESC Scientific Document Group (2019) Fourth universal definition of myocardial infarction (2018). Eur Heart J 40(3):237–269CrossRef
11.
Zurück zum Zitat Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, Onuma Y, Morel MA, van Es GA, Zuckerman B, Fearon WF, Taggart D, Kappetein AP, Krucoff MW, Vranckx P, Windecker S, Cutlip D, Serruys PW (2018) Academic research consortium standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document. Circulation 137(24):2635–2650CrossRefPubMed Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, Onuma Y, Morel MA, van Es GA, Zuckerman B, Fearon WF, Taggart D, Kappetein AP, Krucoff MW, Vranckx P, Windecker S, Cutlip D, Serruys PW (2018) Academic research consortium standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document. Circulation 137(24):2635–2650CrossRefPubMed
12.
Zurück zum Zitat Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Jüni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM; ESC Scientific Document Group (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42(14):1289–1367CrossRef Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Jüni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM; ESC Scientific Document Group (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42(14):1289–1367CrossRef
13.
Zurück zum Zitat Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O’Neill W, Ornato JP, Stelling K, Thiele H, van Diepen S, Naidu SS (2019) SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American heart association (AHA), the society of critical care medicine (SCCM), and the society of thoracic surgeons (STS) in April 2019. Catheter Cardiovasc Interv 94(1):29–37PubMed Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O’Neill W, Ornato JP, Stelling K, Thiele H, van Diepen S, Naidu SS (2019) SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American heart association (AHA), the society of critical care medicine (SCCM), and the society of thoracic surgeons (STS) in April 2019. Catheter Cardiovasc Interv 94(1):29–37PubMed
14.
Zurück zum Zitat Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT, Hoh BL, Janis LS, Kase CS, Kleindorfer DO, Lee JM, Moseley ME, Peterson ED, Turan TN, Valderrama AL, Vinters HV, American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabolism (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(7):2064–2089CrossRefPubMed Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT, Hoh BL, Janis LS, Kase CS, Kleindorfer DO, Lee JM, Moseley ME, Peterson ED, Turan TN, Valderrama AL, Vinters HV, American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabolism (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(7):2064–2089CrossRefPubMed
15.
Zurück zum Zitat Mehran R, Nikolsky E (2006) Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 100:S11–S15CrossRef Mehran R, Nikolsky E (2006) Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 100:S11–S15CrossRef
16.
Zurück zum Zitat Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA (2001) Clopidogrel in unstable angina to prevent recurrent events trial (CURE) investigators effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358(9281):527–533CrossRefPubMed Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA (2001) Clopidogrel in unstable angina to prevent recurrent events trial (CURE) investigators effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358(9281):527–533CrossRefPubMed
17.
Zurück zum Zitat Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM, TRITON-TIMI 38 investigators (2009) Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 373(9665):723–731CrossRefPubMed Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM, TRITON-TIMI 38 investigators (2009) Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 373(9665):723–731CrossRefPubMed
18.
Zurück zum Zitat Kaura A, Sterne JAC, Trickey A, Abbott S, Mulla A, Glampson B, Panoulas V, Davies J, Woods K, Omigie J, Shah AD, Channon KM, Weber JN, Thursz MR, Elliott P, Hemingway H, Williams B, Asselbergs FW, O’Sullivan M, Lord GM, Melikian N, Johnson T, Francis DP, Shah AM, Perera D, Kharbanda R, Patel RS, Mayet J (2020) Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data. Lancet 396(10251):623–634CrossRefPubMedPubMedCentral Kaura A, Sterne JAC, Trickey A, Abbott S, Mulla A, Glampson B, Panoulas V, Davies J, Woods K, Omigie J, Shah AD, Channon KM, Weber JN, Thursz MR, Elliott P, Hemingway H, Williams B, Asselbergs FW, O’Sullivan M, Lord GM, Melikian N, Johnson T, Francis DP, Shah AM, Perera D, Kharbanda R, Patel RS, Mayet J (2020) Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data. Lancet 396(10251):623–634CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(2):87–165CrossRef Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(2):87–165CrossRef
20.
Zurück zum Zitat Bueno H (2015) Medical management: the dark side of acute coronary syndromes. Eur Heart J Cardiovasc Pharmacother 1(3):179–181CrossRefPubMed Bueno H (2015) Medical management: the dark side of acute coronary syndromes. Eur Heart J Cardiovasc Pharmacother 1(3):179–181CrossRefPubMed
21.
Zurück zum Zitat Fox KA, Anderson FA Jr, Dabbous OH, Steg PG, López-Sendón J, Van de Werf F, Budaj A, Gurfinkel EP, Goodman SG, Brieger D, GRACE investigators (2007) Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The global registry of acute coronary events (GRACE). Heart 93(2):177–182CrossRefPubMed Fox KA, Anderson FA Jr, Dabbous OH, Steg PG, López-Sendón J, Van de Werf F, Budaj A, Gurfinkel EP, Goodman SG, Brieger D, GRACE investigators (2007) Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The global registry of acute coronary events (GRACE). Heart 93(2):177–182CrossRefPubMed
22.
Zurück zum Zitat Bauer T, Möllmann H, Weidinger F, Zeymer U, Seabra-Gomes R, Eberli F, Serruys P, Vahanian A, Silber S, Wijns W, Hochadel M, Nef HM, Hamm CW, Marco J, Gitt AK (2011) Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina. Int J Cardiol 151(2):164–169CrossRefPubMed Bauer T, Möllmann H, Weidinger F, Zeymer U, Seabra-Gomes R, Eberli F, Serruys P, Vahanian A, Silber S, Wijns W, Hochadel M, Nef HM, Hamm CW, Marco J, Gitt AK (2011) Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina. Int J Cardiol 151(2):164–169CrossRefPubMed
23.
Zurück zum Zitat Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, TRITON-TIMI 38 Investigators (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001–2015CrossRefPubMed Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, TRITON-TIMI 38 Investigators (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001–2015CrossRefPubMed
24.
Zurück zum Zitat Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Investigators PLATO, Freij A, Thorsén M (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057CrossRefPubMed Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Investigators PLATO, Freij A, Thorsén M (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057CrossRefPubMed
25.
Zurück zum Zitat Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, Cannon CP, Heras M, Lopes RD, Morais J, Mahaffey KW, Bach RG, Wojdyla D, Wallentin L, PLATO study group (2012) Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Circ Cardiovasc Qual Outcomes 5(5):680–688CrossRefPubMed Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, Cannon CP, Heras M, Lopes RD, Morais J, Mahaffey KW, Bach RG, Wojdyla D, Wallentin L, PLATO study group (2012) Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Circ Cardiovasc Qual Outcomes 5(5):680–688CrossRefPubMed
26.
Zurück zum Zitat Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies (2018) 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European society of cardiology (ESC) and of the European association for cardio-thoracic surgery (EACTS). Eur Heart J 39(3):213–260CrossRef Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies (2018) 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European society of cardiology (ESC) and of the European association for cardio-thoracic surgery (EACTS). Eur Heart J 39(3):213–260CrossRef
27.
Zurück zum Zitat Bianco M, Careggio A, Biolè CA, Quadri G, Quiros A, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solè A, Liebetrau C, Manzano-Fernàndez S, Boccuzzi G, Henriques JPS, Spirito A, Templin C, Wilton SB, Velicki L, Correia L, Rognoni A, Ugo F, Nunez-Gil I, Fujii T, Durante A, Song X, Kawaji T, Alexopoulos D, Huczek Z, Gonzàlez Juanatey JR, Nie SP, Kawashiri MA, Morbiducci U, Dominguez-Rodriguez A, Destefanis P, Luciano A, De Ferrari GM, Varbella F, Montagna L, D’Ascenzo F, Cerrato E (2021) Ticagrelor or Clopidogrel after an acute coronary syndrome in the elderly: a propensity score matching analysis from 16,653 patients treated with PCI included in two large multinational registries. Cardiovasc Drugs Ther 35(6):1171–1182CrossRefPubMed Bianco M, Careggio A, Biolè CA, Quadri G, Quiros A, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solè A, Liebetrau C, Manzano-Fernàndez S, Boccuzzi G, Henriques JPS, Spirito A, Templin C, Wilton SB, Velicki L, Correia L, Rognoni A, Ugo F, Nunez-Gil I, Fujii T, Durante A, Song X, Kawaji T, Alexopoulos D, Huczek Z, Gonzàlez Juanatey JR, Nie SP, Kawashiri MA, Morbiducci U, Dominguez-Rodriguez A, Destefanis P, Luciano A, De Ferrari GM, Varbella F, Montagna L, D’Ascenzo F, Cerrato E (2021) Ticagrelor or Clopidogrel after an acute coronary syndrome in the elderly: a propensity score matching analysis from 16,653 patients treated with PCI included in two large multinational registries. Cardiovasc Drugs Ther 35(6):1171–1182CrossRefPubMed
28.
Zurück zum Zitat Akkaif MA, Sha’aban A, Daud NAA, Yunusa I, Ng ML, Sk Abdul Kader MA, Noor DAM, Ibrahim B (2021) Coronary heart disease (CHD) in elderly patients: which drug to choose, Ticagrelor and Clopidogrel? a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Dev Dis 8(10):123CrossRefPubMedPubMedCentral Akkaif MA, Sha’aban A, Daud NAA, Yunusa I, Ng ML, Sk Abdul Kader MA, Noor DAM, Ibrahim B (2021) Coronary heart disease (CHD) in elderly patients: which drug to choose, Ticagrelor and Clopidogrel? a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Dev Dis 8(10):123CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Kruchinova S, Raff SA, Kosmacheva ED (2020) Analysis of hospital mortality in acute coronary syndrome in elderly and long-lived patients. Eur Heart J 41(946):1644 Kruchinova S, Raff SA, Kosmacheva ED (2020) Analysis of hospital mortality in acute coronary syndrome in elderly and long-lived patients. Eur Heart J 41(946):1644
30.
Zurück zum Zitat Murphy JC, Kozor RA, Figtree G, Hansen PS, Rasmussen HH, Ward MR, Nelson GI, Bhindi R (2012) Procedural and in-patient outcomes in patients aged 80 years or older undergoing contemporary primary percutaneous coronary intervention. EuroIntervention 8(8):912–919CrossRefPubMed Murphy JC, Kozor RA, Figtree G, Hansen PS, Rasmussen HH, Ward MR, Nelson GI, Bhindi R (2012) Procedural and in-patient outcomes in patients aged 80 years or older undergoing contemporary primary percutaneous coronary intervention. EuroIntervention 8(8):912–919CrossRefPubMed
31.
Zurück zum Zitat Valente S, Lazzeri C, Salvadori C, Chiostri M, Giglioli C, Poli S, Gensini GF (2008) Effectiveness and safety of routine primary angioplasty in patients aged > or =85 years with acute myocardial infarction. Circ J 72(1):67–70CrossRefPubMed Valente S, Lazzeri C, Salvadori C, Chiostri M, Giglioli C, Poli S, Gensini GF (2008) Effectiveness and safety of routine primary angioplasty in patients aged > or =85 years with acute myocardial infarction. Circ J 72(1):67–70CrossRefPubMed
32.
Zurück zum Zitat Tang EW, Wong CK, Herbison P (2007) Global registry of acute coronary events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 153(1):29–35CrossRefPubMed Tang EW, Wong CK, Herbison P (2007) Global registry of acute coronary events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 153(1):29–35CrossRefPubMed
33.
Zurück zum Zitat Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA (2003) Global registry of acute coronary events investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163(19):2345–2353CrossRefPubMed Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA (2003) Global registry of acute coronary events investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163(19):2345–2353CrossRefPubMed
34.
Zurück zum Zitat Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E (2000) The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284(7):835–842CrossRefPubMed Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E (2000) The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284(7):835–842CrossRefPubMed
35.
Zurück zum Zitat Investigators TRIUMPH, Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, Van de Werf F, Hochman JS (2007) Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 297(15):1657–1666CrossRef Investigators TRIUMPH, Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, Van de Werf F, Hochman JS (2007) Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 297(15):1657–1666CrossRef
36.
Zurück zum Zitat Khera R, Jain S, Pandey A, Agusala V, Kumbhani DJ, Das SR, Berry JD, de Lemos JA, Girotra S (2017) Comparison of readmission rates after acute myocardial infarction in 3 patient age groups (18 to 44, 45 to 64, and ≥65 Years) in the United States. Am J Cardiol 120(10):1761–1767CrossRefPubMedPubMedCentral Khera R, Jain S, Pandey A, Agusala V, Kumbhani DJ, Das SR, Berry JD, de Lemos JA, Girotra S (2017) Comparison of readmission rates after acute myocardial infarction in 3 patient age groups (18 to 44, 45 to 64, and ≥65 Years) in the United States. Am J Cardiol 120(10):1761–1767CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabés JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylén I, Tolosana JM; ESC Scientific Document Group (2021) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 42(35):3427–3520CrossRef Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabés JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylén I, Tolosana JM; ESC Scientific Document Group (2021) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 42(35):3427–3520CrossRef
Metadaten
Titel
Acute coronary syndrome in very elderly patients—a real-world experience
verfasst von
Matteo Bianco
Filiberto Fausto Mottola
Enrico Cerrato
Francesca Giordana
Sebastian Cinconze
Giorgio Baralis
Alison Verra
Giuseppe Musumeci
Roberta Rossini
Publikationsdatum
28.03.2023
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 8/2023
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-023-02260-x

Weitere Artikel der Ausgabe 8/2023

Heart and Vessels 8/2023 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.